1012: Understanding and Navigating the Complexities of Treatment in First Episode Psychosis
Speaker: Peter J. Weiden, MD – Director, Psychosis Treatment Program, Department of Psychiatry, University of Illinois at Chicago
Disclosures: Discussion of off-label uses will not take place during this presentation. The speaker has indicated a significant financial interest or other affiliation with Delpor, Genentech/Roche, Johnson & Johnson (Janssen), Lundbeck, Otsuka USA, Merck, Neurocrine, NIMH, Novartis and Sunovion. The activity planners have no conflicts of interest to disclose.
Session Length: 105 minutes
Target Audience: RN, APRN
Upon completion of this presentation, the participant will be able to:
1. Understand the trajectory of symptoms prior to a “first-episode” presentation to mental health treatment services
2. Understand needs of first-episode patients and families and the clinical modifications from regular care that should be considered during an acute psychotic episode
3. Understand challenges of long-term treatment especially adherence issues for patients who have responded to initial treatment and are beginning long-term treatment for relapse prevention and recovery-oriented care
Continuing Nursing Education
1.75 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.
The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.
Sunday, June 23, 2013 – 7:30am–9:00am
APNA 11th Annual Clinical Psychopharmacology Institute
Release Date: August 5, 2013
The contact hours for this session expire: August 30, 2016